FDA approved - Search News

FDA red food dye ban

FDA bans Red No. 3 food dye in food, drinks: Here's what to know

The FDA announced on Wednesday that it has banned the use of Red No. 3, an additive used to give food and drinks a cherry-red color.

NBC News on MSN · 13h

FDA bans Red Dye No. 3, artificial coloring used in beverages, candy and other foods

The Food and Drug Administration said Wednesday it’s banning the use of Red No. 3, a synthetic dye that gives food and drinks their bright red cherry color but has been linked to cancer in animals.

Providence Journal on MSN · 14h

FDA bans Red No. 3. What has Robert F. Kennedy Jr. said about food dyes?

Manufacturers who use Red No. 3 in food will have until Jan. 15, 2027 to reformulate their products, while those who use the dye in drugs will have until Jan. 18, 2028, according to the FDA announcement. Food imported in the U.S. will also be required to comply with the new regulations.

FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes

The Wall Street Journal on MSN · 11h

Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s disease, an inflammatory bowel disease that causes chronic abdominal pain.

MarketWatch · 10h

Incyte's and Syndax's Graft Disease Treatment Niktimvo Gets FDA Approval for Vial Sizes

Incyte has exclusive commercialization rights for Niktimvo outside the U.S. Niktimvo was approved by the FDA on Aug. 14 for the treatment of chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kilograms.

Seeking Alpha on MSN · 9h

Incyte, Syndax get FDA okay for 9 mg, 22 mg Niktimvo vials

Incyte (NASDAQ:INCY) and Syndax Pharmaceuticals (SNDX) have received FDA approval for their drug Niktimvo in 9 mg and 22 mg vial sizes. Niktimvo was approved in August 2024 for the treatment of chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg,

6hon MSN

US FDA approves expanded use of Lilly's bowel disease drug

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

BioPharma Dive16h

Federal watchdog cites concerns with FDA’s accelerated approval process

The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...

Becker's Hospital Review9h

Watchdog flags flaws in FDA's fast-track drug approvals

The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...

19h

BridgeBio Pharma Is A Buy On Dips After Attruby's FDA Approval

Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone ...

Business Wire2d

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024

SLP highlighted its impact on the pharma industry through support of the development of a majority of the drugs approved by ...

2don MSN

Billed as nonaddictive, new pain pill could soon win FDA approval

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Cure Today10h

The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Hosted on MSN16h

Tempus AI announces national launch of FDA-approved xT CDx test

Tempus AI (TEM) announced the national launch of the company’s FDA-approved, NGS-based in vitro diagnostic device, xT CDx.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA red food dye ban

FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes

Related topics